A 10-Year Longitudinal Study of Brain Cortical Thickness in People with First-Episode Psychosis using Normative Models

Pierre Berthet,Beathe Haatveit,Rikka Kjelkenes,Amanda Worker,Seyed Mostafa Kia,Thomas Wolfers,Saige Rutherford,Dag Alnaes,Richard Dinga,Mads Pedersen,Andreas Dahl,Sara Fernandez-Cabello,Paola Dazzan,Ingrid Agartz,Ragnar Nesvag,Torill Ueland,Ole Andreassen,Carmen Simonsen,Lars T. Westlye,Ingrid Melle,Andre F Marquand
DOI: https://doi.org/10.1101/2024.04.19.24306008
2024-05-27
Abstract:Background: Clinical forecasting models have potential to optimize treatment and improve outcomes in psychosis, but predicting long-term outcomes is challenging and long-term follow up data are scarce. In this 10-year longitudinal study we aimed to characterize the temporal evolution of cortical correlates of psychosis and their associations with symptoms. Design: Structural MRI from people with first-episode psychosis and controls (n=79 and 218) were obtained at enrollment, after 12 months (n=67 and 197), and 10 years (n=23 and 77), within the Thematically Organized Psychosis (TOP) study. Normative models for cortical thickness estimated on public MRI datasets (n=42983) were applied to TOP data to obtain deviation scores for each region and timepoint. Positive And Negative Syndrome Scale (PANSS) scores were acquired at each timepoint along with registry data. Linear mixed effects (LME) models assessed effects of diagnosis, time and their interactions on cortical deviations plus associations with symptoms. Results: LMEs revealed conditional main effects of diagnosis and time x diagnosis interactions in a distributed cortical network, where negative deviations in patients attenuate over time. In patients, symptoms also attenuate over time. LMEs revealed effects of anterior cingulate on PANSS total, and insular and orbitofrontal regions on PANSS negative scores. Conclusions: This long-term longitudinal study revealed a distributed pattern of cortical differences which attenuated over time together with a reduction in symptoms. These findings are not in line with a simple neurodegenerative account of schizophrenia, and deviations from normative models offer a promising avenue to develop biomarkers to track clinical trajectories over time.
What problem does this paper attempt to address?